Results 121 to 130 of about 1,299 (131)

[Chinese guideline on the diagnosis and treatment of adult primary immune thrombocytopenia (2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Thrombosis and Hemostasis Group, Chinese Society of Hematology, Chinese Medical Association.   +2 more
europepmc   +1 more source

[Significance of the 50% hemolytic complement in hemolysis assessment and efficacy of eculizumab in patients with paroxysmal nocturnal hemoglobinuria]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Li L, Huang XY, Ding XQ, Liu ZW, Yang C, Chen M, Yin J, Han B.   +7 more
europepmc   +1 more source

[Acquired factor ⅩⅢ deficiency with FⅩⅢ inhibitor secondary to rheumatoid arthritis: a case report]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zhu BC, Cai HC, Zhang Y, Wang L, Wang W.
europepmc   +1 more source

[Clinical Practice and Quality Control Guidelines for Totally Implantable Venous Access Ports in Cancer Patients (2024)]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Professional Committee Of Interventional Oncology Chinese Anti-Cancer A, Professional Committee On Minimally Invasive Intervention World Association Of Chinese O, Professional Committee Of Intervention Beijing Association Of O.   +2 more
europepmc   +1 more source

[Clinical treatment controversies and progress in liver cirrhosis: an evidence-based medicine perspective from managing portal hypertension to preventing complications]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Yang YF, Wang JJ, Chen GW, Ge QC, Lu LG.
europepmc   +1 more source

[A compulsory course in clinical treatment of burn patients: pain and analgesia]. [PDF]

Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi
Nie FF.
europepmc   +1 more source

[Caplacizumab combined with therapeutic plasma exchange, glucocorticoids, and rituximab for refractory thrombotic thrombocytopenic purpura: a case report and literature review]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Wei QZ, Lu C, Jiang HW, Hu JB, Wu YH, Hu Y.   +5 more
europepmc   +1 more source